Utah Medical Stock Insiders
| UTMD Stock | USD 63.98 -1.37 -2.10% |
Below is a snapshot of Utah Medical's ownership structure and how that base is positioned today. Institutions own 71.56% of Utah Medical and insiders hold 7.17%. The split between insider and institutional ownership shapes governance dynamics and voting outcomes.
| Kevin Cornwell Chairman Chairman, CEO and President & Secretary |
Utah Medical |
Utah Medical's Workforce Through the Years
Employee-history analysis for Utah Medical reveals whether the business is expanding capacity, defending margins, or adjusting to softer demand. Reported staffing levels near about 380 employees reflect the current operating footprint and warrant comparison with broader business results. Reported workforce figures may vary across disclosures and time periods; aggregated or historical datasets can reflect different figures depending on reporting scope and methodology.Macro event markers
Management Team Effectiveness
UTMD has return on total asset (ROA) of 6.16% suggesting that the asset base is earning positive returns for the period. This is neither notably high nor low for the sector. Utah Medical also reports a return on stockholder's equity (ROE) of 9.14%, suggesting that shareholder equity is earning positive returns for the period.Based on figures reported as of December 31, 2025, Common Stock Shares Outstanding is broadly unchanged at 3.24 million.
Stock Institutional Investors
At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. The holder split in Utah Medical Products separates passive index allocation from active institutional positioning. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Volume spikes around index rebalance dates warrant attention given the high institutional share.
| Shares | Huber Capital Management Llc | 2025-12-31 | 36.8 K | Bank Of New York Mellon Corp | 2025-12-31 | 35.5 K | Northern Trust Corp | 2025-12-31 | 29.3 K | Cardinal Capital Management | 2026-03-31 | 26.5 K | Quantinno Capital Management Lp | 2025-12-31 | 23.7 K | Everett Harris & Co | 2025-12-31 | 21.3 K | Bard Associates Inc | 2025-12-31 | 18.2 K | Millennium Management Llc | 2025-12-31 | 16.3 K | Qube Research & Technologies | 2025-12-31 | 15.3 K | Brandes Investment Partners & Co | 2025-12-31 | 351.3 K | Dimensional Fund Advisors, Inc. | 2026-03-31 | 197.9 K |
Insider Trading Activities
Reviewing insider trades in Utah Medical Products shows whether management is acting in line with the public story on growth and strategy. It trades on NASDAQ in US. The business currently sits in the Healthcare sector and the Medical Instruments & Supplies industry.
Timken Kevin a day ago Insider Trading | ||
Timken Kevin 2 days ago Insider Trading | ||
Timken Kevin 3 days ago Insider Trading | ||
Timken Kevin few days ago Insider Trading | ||
Timken Kevin six days ago Insider Trading | ||
Timken Kevin over a week ago Insider Trading | ||
Timken Kevin over a week ago Insider Trading | ||
Timken Kevin over a week ago Insider Trading | ||
Timken Kevin over a week ago Insider Trading | ||
Timken Kevin over a week ago Insider Trading | ||
Timken Kevin over two weeks ago Insider Trading | ||
Timken Kevin over two weeks ago Insider Trading |
Outstanding Bonds
Corporate bonds issued by Utah Medical Products matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley Jul Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Corporate Filings
8K | 4th of May 2026 Report filed with the SEC to announce major events that shareholders should know about | |
8K | 23rd of April 2026 Report filed with the SEC to announce major events that shareholders should know about | |
| 2nd of April 2026 Other Reports | ||
13A | 27th of March 2026 An amended filing to the original Schedule 13G | |
8K | 29th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | |
F3 | 18th of December 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | |
F4 | 25th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | |
10Q | 14th of November 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations |
Shares in Circulation | First Issued 1987-03-31 | Previous Quarter 3.2 million | Current Value 3.19 million | Average Shares Outstanding 6.09 million | Quarterly Volatility 3.16 million |
Macro event markers
Holders Distribution
For Utah Medical Products, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.
Market Cap and Value
Workforce Comparison
Utah Medical Products is rated below average for number of employees relative to top peers. The total workforce of Health Care industry is at this time estimated at about 2,968. Utah Medical holds roughly 140 in number of employees claiming about 5% of equities under Health Care sector.
Profit Margins
UTMD has Profit Margin (PM) of 29.0%. Similarly, it shows Operating Margin (OM) of 29.0%.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 44.00% | 51.60% |
|
| |||||
| Net Profit Margin | 21.00% | 29.30% |
|
| |||||
| Operating Profit Margin | 26.00% | 29.60% |
|
| |||||
| Pretax Profit Margin | 27.00% | 36.63% |
|
| |||||
| Return On Assets | 8.75% | 9.21% |
|
| |||||
| Return On Equity | 8.99% | 9.46% |
|
|
Insider Trading History
The insider trade history for Utah Medical Products reveals whether executives were buying or selling during key price moves. Pattern analysis matters more than any single trade. The full record tells the real story.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2022-12-01 | 0.3333 | 2 | 6 | 1,500 | 1,581 |
| 2021-12-01 | 0.3333 | 3 | 9 | 811.00 | 10,244 |
| 2020-03-01 | 1.0 | 1 | 1 | 2,000 | 500.00 |
| 2018-12-01 | 0.3333 | 1 | 3 | 1,600 | 1,275 |
| 2018-03-01 | 0.0769 | 1 | 13 | 938.00 | 18,708 |
| 2017-03-01 | 1.0 | 1 | 1 | 1,000.00 | 1,000.00 |
| 2016-12-01 | 0.0769 | 1 | 13 | 1,000.00 | 17,406 |
| 2016-06-01 | 0.25 | 1 | 4 | 1,050 | 1,717 |
| 2015-06-01 | 0.5 | 2 | 4 | 9,329 | 14,216 |
| 2014-12-01 | 0.25 | 1 | 4 | 1,500 | 5,172 |
| 2014-06-01 | 0.6667 | 2 | 3 | 4,933 | 6,146 |
| 2013-12-01 | 0.0833 | 1 | 12 | 250.00 | 9,941 |
| 2013-03-01 | 0.5 | 3 | 6 | 12,588 | 22,118 |
| 2012-12-01 | 0.125 | 2 | 16 | 12,400 | 22,750 |
| 2012-06-01 | 0.6667 | 2 | 3 | 10,650 | 11,050 |
| 2012-03-01 | 1.5 | 3 | 2 | 17,075 | 16,000 |
| 2011-06-01 | 1.0 | 2 | 2 | 12,250 | 12,450 |
| 2010-03-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
| 2009-06-01 | 1.0 | 2 | 2 | 400.00 | 625.00 |
| 2007-12-01 | 0.5 | 2 | 4 | 625.00 | 2,030 |
| 2007-03-01 | 0.6 | 6 | 10 | 17,000 | 22,841 |
| 2006-09-01 | 0.25 | 1 | 4 | 2,000 | 3,846 |
| 2006-03-01 | 0.6667 | 14 | 21 | 239,871 | 381,671 |
| 2005-12-01 | 0.3529 | 6 | 17 | 106,470 | 184,281 |
| 2005-09-01 | 1.0 | 1 | 1 | 9,824 | 9,824 |
| 2005-06-01 | 1.1429 | 8 | 7 | 45,305 | 48,284 |
| 2005-03-01 | 0.75 | 3 | 4 | 9,000 | 19,000 |
| 2004-12-01 | 0.8333 | 5 | 6 | 10,511 | 19,485 |
| 2004-06-01 | 0.7143 | 10 | 14 | 74,736 | 81,911 |
| 2004-03-01 | 0.75 | 3 | 4 | 56,000 | 21,885 |
| 2003-12-01 | 0.75 | 3 | 4 | 14,764 | 16,389 |
| 2003-09-01 | 1.5 | 6 | 4 | 47,587 | 27,220 |
Notable Stakeholders
Stakeholders matter for Utah Medical because not every influential participant is a shareholder acting with the same objective or time horizon. In practice, stakeholder review supports awareness of the people and incentives that may be shaping key decisions behind the scenes.
| Kevin Cornwell | Chairman, CEO and President & Secretary | Profile | |
| Marcena Clawson | Vice President of Corporate Sales | Profile | |
| Mark Fox | Vice President of Marketing | Profile | |
| Brian Koopman | Principal Financial Officer, Accounting Manager & Controller | Profile |
Management Information & Data Sources
Utah Medical is a micro-cap company across Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Leadership tenure and executive continuity help assess whether strategic vision is being maintained across cycles. Leadership stability across market cycles increases confidence in long-range planning and execution. CEO is Kevin Cornwell with 140 employees and 4 reported executives.
Reported values for Utah Medical Products are derived from periodic company reporting and market reference feeds and standardized for analysis. Insider and management fields are mapped from published filings and company disclosures.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Workforce Efficiency and Productivity
Workforce efficiency at Utah Medical Products reveals how effectively labor resources are being converted into revenue and earnings over time. When applied, manpower metrics highlight whether growth is being supported by better productivity or by heavier staffing costs.
Utah Medical Manpower Efficiency
Return on Utah Medical Manpower
| Revenue Per Employee | 275.1K | |
| Revenue Per Executive | 9.6M | |
| Net Income Per Employee | 80.6K | |
| Net Income Per Executive | 2.8M | |
| Working Capital Per Employee | 679.6K | |
| Working Capital Per Executive | 23.8M |
Popular Tools for Utah Medical Stock analysis
CEOs DirectoryScreen CEOs from public companies around the worldOdds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 yearsPortfolio HoldingsCheck your current holdings and cash position to determine if your portfolio needs rebalancingPortfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for riskCommodity ChannelUse Commodity Channel Index to analyze current equity momentumShare PortfolioTrack or share privately all of your investments from the convenience of any deviceBonds DirectoryFind actively traded corporate debentures issued by US companiesCompanies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentalsGlobal Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes